Related Experiment Video

Updated: Apr 25, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

17.8K

Pleiotrophin inhibits melanogenesis via Erk1/2-MITF signaling in normal human melanocytes

Woo Jong Choi1, Misun Kim, Ji-Youn Park

  • 1Department of Dermatology, Ajou University School of Medicine, Suwon, Korea; Department of Biochemistry and Molecular Biology, Ajou University School of Medicine, Suwon, Korea.

Pigment Cell & Melanoma Research
|August 22, 2014
PubMed

Insights

Pleiotrophin (PTN) inhibits skin pigmentation by decreasing melanogenesis. This secreted protein likely reduces melanin production through MITF degradation in melanocytes, impacting skin color regulation.

Area of Science:

  • Dermatology
  • Cell Biology
  • Biochemistry

Background:

  • Pleiotrophin (PTN) is a secreted protein with known roles in cell growth and differentiation.
  • The specific impact of PTN on melanocyte function and skin pigmentation remains largely unexplored.

Purpose of the Study:

  • To investigate the effect of Pleiotrophin (PTN) on melanogenesis, the process of melanin production.
  • To elucidate the molecular mechanisms underlying PTN's influence on skin pigmentation.

Main Methods:

  • PTN expression analysis in human skin melanocytes and fibroblasts.
  • Transfection studies in melanocytes to assess PTN's effect on melanogenesis.
  • Ex vivo skin culture and co-culture models to validate findings.

Main Results:

  • PTN is expressed in human skin melanocytes and fibroblasts.
  • PTN significantly decreased melanogenesis in melanocytes.
  • PTN-induced reduction in melanogenesis is associated with MITF degradation via Erk1/2 activation.
  • Inhibitory effects on pigmentation were confirmed in ex vivo skin and co-culture models.

Conclusions:

  • Pleiotrophin (PTN) acts as a negative regulator of melanogenesis in the skin.
  • PTN influences skin pigmentation, potentially through the MITF degradation pathway.
  • These findings identify PTN as a key factor in regulating skin melanin production.
Keywords:
Erk1/2MITFmelanocytesmelanogenesispleiotrophin

More Related Videos

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues08:06

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues

Published on: July 8, 2020

5.1K
Quantification of Hypopigmentation Activity In Vitro06:08

Quantification of Hypopigmentation Activity In Vitro

Published on: March 6, 2019

11.2K

Related Concept Videos

Pigmentation01:19

Pigmentation

The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K